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The tropical bont tick, Amblyomma variegatum, is a tick species of veterinary
importance and is considered as one of major pest of ruminants in Africa and in
the Caribbean. It causes direct skin lesions, transmits heartwater, and reactivates
bovine dermatophilosis. Tick saliva is reported to affect overall host responses
through immunomodulatory and anti-inflammatory molecules, among other bioactive
molecules. The general objective of this study was to better understand the role
of saliva in interaction between the Amblyomma tick and the host using cellular
biology approaches and proteomics, and to discuss its impact on disease transmission
and/or activation. We first focused on the immuno-modulating effects of semi-fed
A. variegatum female saliva on bovine peripheral blood mononuclear cells (PBMC)
and monocyte-derived macrophages in vitro. We analyzed its immuno-suppressive
properties by measuring the effect of saliva on PBMC proliferation, and observed a
significant decrease in ConA-stimulated PBMC lymphoproliferation. We then studied
the effect of saliva on bovine macrophages using flow cytometry to analyze the
expression of MHC-II and co-stimulation molecules (CD40, CD80, and CD86) and by
measuring the production of nitric oxide (NO) and pro- or anti-inflammatory cytokines.
We observed a significant decrease in the expression of MHC-II, CD40, and CD80
molecules, associated with decreased levels of IL-12-p40 and TNF-α and increased
level of IL-10, which could explain the saliva-induced modulation of NO. To elucidate
these immunomodulatory effects, crude saliva proteins were analyzed using proteomics
with an Orbitrap Elite mass spectrometer. Among the 336 proteins identified in
A. variegatum saliva, we evidenced bioactive molecules exhibiting anti-inflammatory,
immuno-modulatory, and anti-oxidant properties (e.g., serpins, phospholipases A2,
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heme lipoprotein). We also characterized an intriguing ubiquitination complex that could
be involved in saliva-induced immune modulation of the host. We propose a model for
the interaction between A. variegatum saliva and host immune cells that could have an
effect during tick feeding by favoring pathogen dissemination or activation by reducing
the efficiency of host immune response to the corresponding tick-borne diseases.
Keywords: Amblyomma variegatum, tick saliva, PBMC, immuno-modulation, proteomics
INTRODUCTION
Amblyomma variegatum is among the most important and
widely distributed ticks of tropical livestock, and is the subject
of veterinary and public health concerns in Africa and islands
in the Indian Ocean and the Caribbean (Stachurski et al., 2010;
Bournez et al., 2015). The species is the natural vector of Ehrlichia
ruminantium, the Rickettsia that causes heartwater in ruminants
(Allsopp, 2010), and can also transmit human pathogens
including several species of Rickettsia and viruses (Jongejan
and Uilenberg, 2004). Moreover, A. variegatum has been
proven to reactivate the development of dermatophilosis, a skin
disease with major economic impacts caused by Dermatophilus
congolensis (Martinez et al., 1992).
Generally, at the bite site, ticks are able to inhibit pain and
itch, inflammation, hemostasis, and wound healing, but also
to modulate the host innate and adaptive immune responses,
which consequently favor transmission of infectious agents
(Šimo et al., 2017). The coevolution between ticks, hosts and
pathogens has led to a balance of conflicts and cooperations
between the different actors, which mainly benefit the ticks
and pathogens. Nevertheless, increased production of antibodies
against molecular determinants of tick saliva could also increase
protection against pathogen infection (Wade, 2007; Wikel,
2013; de la Fuente et al., 2016). In tick-host interactions,
tick saliva is the source of biologically active molecules that
target a wide spectrum of host physiological mechanisms,
mainly inhibiting host defense reactions to the benefit of the
feeding ticks (Kazimírová and Štibrániová, 2013; Stibrániová
et al., 2013). The immediate inflammatory response to the skin
injury induces rapid infiltration of leukocytes at the tick bite
site, where both resident and infiltrated cells (keratinocytes,
endothelial cells, mast cells, dendritic cells, macrophages,
and lymphocytes) are activated by direct contact with tick
saliva (Brossard and Wikel, 2004; Francischetti et al., 2009;
Wikel, 2013). Omics analyses have enabled the comprehensive
characterization of the molecular determinants of tick saliva,
with a functional involvement of these bioactive molecules in
host immune suppression (Kotál et al., 2015; Chmelar et al.,
2016a,b).
The saliva of Amblyomma ticks has been the subject of
extensive biochemical studies since the early 2000s (Karim et al.,
2004, 2011;Madden et al., 2004;Mulenga et al., 2013; Garcia et al.,
2014; Araujo et al., 2016), but only a few have been devoted to the
sialome of A. variegatum. These studies revealed new families of
tick-exclusive proteins (Knizetova et al., 2006; Koh et al., 2007;
Ribeiro et al., 2011), some related to suppression of inflammation
(Tian et al., 2016).
In the present study, using crude saliva from A. variegatum
semi-fed females (i.e., at the peak of salivation), our
aim was to (i) explore the impact of saliva in vitro on
bovine immune cells and (ii) determine the molecular
immunomodulators. The originality of our approach was
to combine cellular experiments, demonstrating modulation
of lymphocyte proliferation and macrophage activation, with
proteomic analysis of saliva to identify and characterize the
immunomodulatory proteins potentially responsible for the
observed biological effects. Consequences on host response to
infestation by A. variegatum and transmission of pathogens are
discussed.
MATERIALS AND METHODS
A. variegatum Saliva Production
Ten A. variegatum female ticks were engorged on naïve creole
goats, in accordance with the experimental procedure of the
project in animal experimentation approved by the ethics
committee Antilles-Guyane (Project Number 69 registered by
Comité National de Réflexion Ethique sur l’Expérimentation
Animale). After 5–7 days, the female ticks were detached at a
semi-fed stage and injected in the hemocoele with a Hamilton
syringe with 10 µl of a 5% (w/v in PBS) pilocarpine solution
to stimulate saliva production. A capillary micropipette placed
around the tick hypostome was used to collect the saliva from
ticks (duration of salivation about 30min), and fresh crude
saliva was aliquoted and immediately stored at −80◦C for
further use. For cellular tests, three different pools of saliva
were obtained from 10 A. variegatum semi-fed female ticks.
For proteomic analyses, crude saliva, from either individual
ticks’ saliva or pools of saliva, was processed directly according
the standardized protocol (see below). Protein concentration
was measured with a Nanodrop 1000 (ThermoScientific).
The concentration of Pilocarpine in the saliva was evaluated
using an HPLC-MS/MS method proposed by Ribeiro et al.
(2004). Contrary to the pilocarpine concentrations previously
reported for A. americanum (Ribeiro et al., 2004), we did not
detect in our study a concentration of salivary pilocarpine
higher than 5 nM, which was set as our pilocarpine control
concentration.
Purification of Bovine PBMCs and
Proliferation Assay
Peripheral blood was collected in lithium heparin tubes
(BD Biosciences, Le Pont de Claix, France) from three
healthy female Jersiaise cattle aged between 4 and 6 years
(APAFIS#14442015081310300000). PBMC were isolated by
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differential centrifugation over Histopaque 1083 R© (Sigma
Aldrich, St. Quentin, France) and washed twice in calcium and
magnesium free Hanks balanced salt solution (Life Technologies,
Saint Aubin, France). PBMC were suspended at 2.5 × 106
cells/ml in RPMI-1640 culture medium (Life Technologies, Saint
Aubin, France) supplemented with 2mM L-glutamine (Sigma
Aldrich, St. Quentin, France), 5 × 10−5 M β2-mercaptoethanol
(Sigma Aldrich, St. Quentin, France), 50µg/ml gentamycin
(Sigma Aldrich, St. Quentin, France), and 10% heat-inactivated
fetal calf serum (Life Technologies, Saint Aubin, France).
One hundred microliters of PBMC (2.5 × 105 cells) were
distributed in triplicate in the wells of a 96-well microplate
and the cells were stimulated with 2.5µg/ml of Concanavalin
A (ConA, Sigma Aldrich, St Quentin, France) either alone
(positive control corresponding to 100% of stimulation) or
in the presence of A. variegatum saliva at concentrations
ranging from 0.3 to 37.5µg/ml for 72 h at 37◦C with 5%
CO2. PBMC were also tested with saliva alone, without ConA
stimulation, and with pilocarpine at 5 nM. Cell proliferation
was measured using the CyQUANT Direct Cell Proliferation
Assay kit (Molecular Probes/ThermoFisher Scientific, Paisley,
UK) according to the manufacturer’s instructions. Briefly, 100
µl of the 2X detection reagent were added to the cells for a
further 60min of incubation at 37◦C, 5% CO2. The fluorescence
of samples was then read at 480/535 nm using an Enspire
Multimode Plate Reader (Perkin Elmer, Courtaboeuf, France).
Fluorescence in samples treated with ConA and saliva was
compared with fluorescence measured with ConA alone to
calculate the relative PBMC activation percentage. Similarly,
fluorescence in unstimulated PBMC treated with saliva was
compared with fluorescence measured in unstimulated cells.
Experiments were performed using cells from three different
animals (1973, 9567, and 9906), each of the three saliva batches
being tested separately. Data are presented as relative PBMC
activation, means of values obtained for the three batches of saliva
(for each concentration) in triplicate experiments for each of the
three animals.
Preparation of Bovine Macrophages and
Stimulation Assay
Immuno-magnetic separation of CD14+monocytes from PBMC
was carried out using anti-human CD14 antibody (TUK4)
coated beads (Miltenyi Biotec, Bergish Gladbach, Germany),
according to the manufacturer’s instructions. Flow cytometry
analysis was carried out on the positively selected populations
and confirmed that the purity of the population was >95%.
Bovine monocytes were suspended in complete IMDM (Life
Technologies, Saint Aubin, France) supplemented with 2mM L-
glutamine (Sigma, Saint-Quentin, France), 10% heat-inactivated
fetal calf serum (Life Technologies, Saint-Aubin, France), 5 ×
10−5 M β2-mercaptoethanol (Sigma, Saint-Quentin, France), and
50µg/ml gentamicin (Life Technologies, Saint-Aubin, France).
One hundred microliters of cells at 1.106 cells/ml were seeded
into 96-well plates (for NO production) or 500 µl of cells were
seeded into 48-well plates (for production of cytokines and
analysis of co-stimulation surface markers). Half the culture
medium was replaced every 3 days by complete IMDM,
supplemented with GM-CSF and INF-γ for NO induction in
the 96-well plate. After 7 days of culture, more than 95% of
cells had the morphological characteristics of macrophages. At
day 7, 100 ng/ml of ultrapure LPS from E. coli (InVivoGen,
Toulouse, France) was added for 1 h prior to saliva stimulation,
alone or in the presence of A. variegatum saliva at concentrations
ranging from 7.8125 to 250µg/ml for an additional 24 h
at 37◦C with 5% CO2. Pilocarpine (5 nM) was also tested.
Cells were also tested without LPS pre-stimulation, with the
different concentrations of saliva or with 5 nM of pilocarpine.
Supernatants were collected from the 96-well plate and NO
concentration was immediately determined using the Griess
method. Supernatants were collected from the 48-well plate for
TNF-α, IL-12, and IL-10 quantification by ELISA, according to
the protocols of Hope et al. (2002) and Kwong et al. (2002,
2010). Briefly, 5µg/ml of capture Mabs CC327, CC301, and
CC318 for TNF-α, IL-12, and IL-10, respectively (Bio-Rad
AbDSerotec, UK) were used as coating antibodies, cultures were
left overnight at+4◦C. After washing and blocking with 1 mg/ml
of casein (Sigma Aldrich, Saint Quentin, France), cell culture
supernatants and serial diluted standards were incubated for
1 h at room temperature. Wells were washed and a 8µg/ml
solution of biotinylated detection Mabs (biotinylated-CC328,
-CC326, and -CC320, all from Bio-Rad AbD Serotec, UK)
were added for 1 h, detected by Streptavidin-HRP (eBiosciences,
France) and revealed with TMB liquid substrate system for
ELISA (Sigma Aldrich, France). The reaction was stopped with
H2SO4 0.5M and the plates were read at 450 nm. All the
results were determined with standard curves obtained with
serial dilutions of recombinant proteins (ref. RBOTNFA for
TNF-α from Pierce, Rockford, USA; ref. 87464 from AbCam,
France for IL-12 and ref. RPO379 for IL-10 from Kingfisher,
USA).
Cells in the 48-wells plate were collected and labeled with
mouse anti bovine monoclonal antibodies for analysis of co-
stimulation surface markers: MHC II (clone J11, kindly provided
by ILRI, Kenya), CD40 (clone IL-A156, AbD Serotec, UK), CD80
(clone IL-A159, AbD Serotec, UK), and CD86 (clone IL-A190,
AbD Seroteck, UK). Isotypic control was used as non-specific
labeling (MCA928, AbD Serotec, UK). Antibodies were revealed
using goat anti mouse IgG1-RPE (STAR132PE, AbD Serotec,
UK), cells were processed for flow cytometry using a FacsCanto
II cytometer (BD Biosciences, USA) and data were analyzed
using Diva software (BD Biosciences, USA) for FCS/SSC and FL2
fluorescence intensities. Relative expression in MFI (median of
fluorescence intensities) was calculated by comparing stimulated
cell (without saliva or with different saliva concentrations) MFI
with unstimulated cell MFI. Experiments were performed with
cells from three different animals (1973, 9567, and 9906), and
tested with a pool of saliva from the three batches.
Proteomics Analysis of A. variegatum
Saliva
A. variegatum saliva proteins (10 µg) were separated on SDS-
PAGE gels (12% polyacrylamide, Mini-PROTEAN R© TGXTM
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Precast Gels, Bio-Rad, Hercules USA) and stained with Protein
Staining Solution (Euromedex, Souffelweyersheim France). Gel
lanes were cut into three continuous gel pieces that were
treated independently, in order to isolate majority proteins
and to allow identification of low quantity proteins. Gel pieces
were first destained with 50mM triethylammonium bicarbonate
(TEABC) and three washes in 100% acetonitrile. After protein
reduction (with 10mM dithiothreitol in 50mM TEABC at
56◦C for 45min) and alkylation (55mM iodoacetamide TEABC
at room temperature for 30min) proteins were digested in-
gel using trypsin (500 ng/band, Gold, Promega, Madison
USA) as previously described (Thouvenot et al., 2008). Digest
products were dehydrated in a vacuum centrifuge and reduced
to 3 µL. The generated peptides were analyzed by nano-
flowHPLC–nanoelectrospray ionization using an Orbitrap Elite
mass spectrometer (Thermo Fisher Scientific, Waltham USA)
coupled to an Ultimate 3000 HPLC (Thermo Fisher Scientific).
Desalting and pre-concentration of samples were performed
online on a Pepmap R© pre-column (0.3 × 10mm, Dionex).
A gradient consisting of 0–40% B for 60min and 80% B for
15min (A = 0.1% formic acid, 2% acetonitrile in water; B =
0.1% formic acid in acetonitrile) at 300 nL/min was used to
elute peptides from the capillary reverse-phase column (0.075 ×
150mm, Acclaim Pepmap 100 R©C18, Thermo Fisher Scientific).
Eluted peptides were electro-sprayed online at a voltage of 1.9
kV into an Oribtrap Elite mass spectrometer. A cycle of one
full-scan mass spectrum (400–2,000 m/z) at a resolution of
120,000 (at 400 m/z), followed by 20 data-dependent MS/MS
spectra was repeated continuously throughout the nanoLC
separation. All MS/MS spectra were recorded using normalized
collision energy (33%, activation Q 0.25 and activation time
10ms) with an isolation window of 2 m/z. Data were acquired
using Xcalibur software (v 2.2). For all full scan measurements
with the Orbitrap detector a lock-mass ion from ambient
air (m/z 445.120024) was used as an internal calibrant as
described in Olsen et al. (2005). MS data were analyzed using
the MaxQuant software package (v 1.5.0.0) as described by
Cox and Mann (2008). Tandem mass spectra (MS/MS) were
searched for using the Andromeda search engine (Cox et al.,
2011) against the UniProtKB database (release 2015_03) for the
A. variegatum (AMBVA) taxonomy (753 entries), Amblyomma
“all species” taxonomy (22,429 entries), and the UniProtKB
proteome UP000001555 database for Ixodes scapularis (20,473
entries) using the following parameters: enzyme specificity was
set as Trypsin/P, and a maximum of two missed cleavages and
a mass tolerance of 0.5 Da for fragment ion were applied.
A second database of known contaminants provided with the
MaxQuant suite was also used. The “match between runs”
option was checked. Oxidation (M) was specified as variable
modification and carbamidomethyl (C) as fixed modification.
Database searches were performed with a mass tolerance of 20
ppm for precursor ion for mass calibration, and with a 4.5
ppm tolerance after calibration. The maximum false peptide and
protein discovery rate was set at 0.01. The MaxQuant software
generates several output files that contain information about
the peptides and proteins identified. The “proteinGroups.txt”
file is dedicated to identified proteins: each single row collapses
all proteins that cannot be distinguished based on identified
peptides into protein groups. An in-house bioinformatics tool
was developed to automatically select a representative protein ID
in each protein group. First, proteins with the most identified
peptides were isolated in a group called “match group” [proteins
from the “Protein IDs” column with the maximum number
of “peptides counts (all)”]. For 35% of the remaining match
groups in which more than one protein ID existed, the “leading”
protein was chosen as the best annotated protein according
to the number of gene ontology annotations (retrieval from
UniProtKB March 20, 2015) and/or given the following species
order preference:A. variegatum>A. maculatum>A. cajennense
> A. parvum > A. americanum > A brasiliense > A. triste > A.
geayi > A. scutatum > A. rotundatum. The mass spectrometry
data along with the identification results were deposited in
the ProteomeXchange Consortium via the PRIDE (Martens
et al., 2005) partner repository with the dataset identifier
PXD007821.
Bioinformatics Analysis of Proteomics
Data
We used several web servers to investigate the biochemical
properties of the identified proteins.
The ProtFun 2.2 server produces ab initio predictions of
protein function from sequences. The method queries a large
number of other feature prediction servers to obtain information
on various post-translational and localizational aspects of the
protein, which are integrated in final predictions of the cellular
role, enzyme class (if any), and selected gene ontology (GO)
categories of the submitted sequence (Jensen et al., 2002, 2003).
Propsearch server is designed to find the putative protein
family if querying a new sequence using alignment methods
has failed. Disregarding the order of amino acid residues
in a sequence, Propsearch uses the amino acid composition
instead. In addition, other properties likemolecular weight, bulky
residue content, small residue content, average hydrophobicity,
average charge a.s.o. and the content of selected dipeptide-
groups are also calculated from the sequence. A total of 144
such properties are weighted individually and used as query
vectors. The weights have been trained on a set of protein
families with known structures, using a genetic algorithm.
Sequences in the database are also transformed into vectors,
and the Euclidian distance between the query and database
sequences is calculated. Distances are rank ordered, and
sequences with lowest distance are reported on top (Hobohm and
Sander, 1995). We used Propsearch first to better characterize
proteins identified as “Putative Uncharacterized Protein” and
second to improve the potential functional information on the
identified proteins. In our analytical strategy, we conserved
only data for proteins with Euclidian distances between 0.0
and 1.3 (Reliability 99.9%) and between 1.3 and 7.5 (Reliability
99.6%).
Statistical Tests
Graphs and linear modeling were performed with R version 3.4.1
(R Core Team, 2013) and the tidyverse package (v 1.1.1). Datasets
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and figures along with the script are available at: https://github.
com/loire/amblyoma_paper.
RESULTS
Inhibition of ConA-Induced PBMC
Proliferation by A. variegatum Saliva
To investigate the effect of A. variegatum on PBMC proliferation,
cells were stimulated with ConA alone (positive control
for PBMC activation) or with various concentrations of
saliva for 72 h, and the relative PBMC activation for each
saliva concentration vs. no saliva (positive control) was
calculated. As shown in Figure 1, the relative PBMC activation
decreased in a dose-dependent manner when cells were
in contact with A. variegatum saliva. A concentration of
1.2µg/ml of saliva reduced the ConA-induced proliferation
of PBMC by 9–13%, depending on the animal from which
the cells originated (Figure 1). The decrease in proliferation
was linear depending on the concentration of the saliva,
and reached 24–36% for 18.75µg/ml of saliva (Figure 1).
Saliva concentrations of <1.2µg/ml was tested and did not
result in statistically significant inhibition of ConA-induced
PBMC proliferation, whereas levels of inhibition for higher
concentrations (>18.75µg/ml) were similar to those for
18.75µg/ml (data not shown). Unstimulated PBMC incubated
with saliva did not show any proliferation and pilocarpine control
had no effect on ConA-induced PBMC proliferation (data not
shown).
Modification of LPS Pre-stimulated
Macrophage Activation by A. variegatum
Saliva
We tested the effects of various concentrations of A. variegatum
saliva on MHC II and co-stimulation molecules (CD40, CD80,
and CD86) on LPS pre-stimulated macrophages. As shown in
Figure 2, in all conditions tested, A. variegatum saliva had a
biological effect on the expression of co-stimulation surface
markers in LPS pre-stimulated macrophages, compared to
unstimulated cells (no LPS). Saliva enhanced the LPS-induced
down regulation of macrophages MHC II from 23 to 62%, from
39 to 72%, or from 60 to 75% depending on both the saliva
concentration and the animal (overall p = 0.092, specific p <
0.05), and decreased the LPS-induced up regulation of both
CD40 and CD80 in a dose-dependent manner (Figure 2). The
saliva had no obvious effect on LPS-induced down regulation
of CD86, which was already strongly decreased by LPS alone
(Figure 2). The three independent animals gave similar profiles
with individual variability in the level of expression of the co-
stimulatory surface markers but, as shown in Figure 2, the
trend curve shows that the individual variations all followed
the same pattern. The effect of A. variegatum saliva alone
on macrophages, without pre-stimulation with LPS, was less
striking, with marked individual variability between animals:
MHC II and CD86 were down regulated in a dose-dependent
manner, CD40 and CD80 were up regulated in two out of three
animals with no dose-dependence, CD86 was down regulated
in a dose-dependent manner (Supplementary Figure 1). Percent
expression of CD40 and CD80 induced by saliva alone
was 10 times lower than that with LPS pre-stimulation
(Supplementary Figure 1). Macrophages derived from animal
n◦ 1973 exhibited a difference MHC II levels depending on
the concentration of the saliva compared to the other animals:
expression increased for 31.25µg/ml of saliva, then decreased
for 62.5µg/ml, increased slightly for 125µg/ml and decreased
slightly for 250µg/ml. Same kind of inverted fluctuations were
observed with animal n◦ 9906 for CD80 and animal n◦ 9567 for
CD86 (Supplementary Figure 1).
As shown in Figure 3, LPS pre-stimulated macrophages
produced NO and production was increased by adding up to
62.5µg/ml of A. variegatum saliva, but decreased at higher
saliva concentrations (125 and 250µg/ml). The production of
cytokines was also affected: IL-12 and TNF-α levels decreased
dramatically, from a concentration of 31.25µg/ml of saliva,
except for animal n◦ 1973, in which a small dose-dependent
decrease in TNF-α was observed (Figure 3). In contrast, the IL-
10 level was increased by saliva in a dose-dependent manner
(Figure 3). The three independent animals exhibited similar NO
profiles and cytokine production, with individual variability in
the levels reached but, like for co-stimulation surface markers,
the trend curve showed that the individual variations all followed
the same pattern. The effect of saliva alone on unstimulated cells
resulted in very low levels of cytokine production, with increased
FIGURE 1 | Effect of A. variegatum saliva on ConA-induced proliferation of
bovine PBMC. Bovine PBMC were stimulated with ConA alone or with
different concentrations of A. variegatum saliva for 72 h. PBMC responses of
cells in contact with ConA and saliva were compared to PBMC in contact with
ConA alone (control) to calculate “relative PBMC activation.” Data are means
of triplicate experiments, for each batch of saliva for the three animals tested.
Blue lines and shading show respectively the linear regression fit and the 0.95
confidence interval. The p-value of the model is indicated on the panel.
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FIGURE 2 | Effect of A. variegatum saliva on the expression of surface markers on LPS-stimulated bovine macrophages. Bovine blood monocyte-derived
macrophages were pre-stimulated for 1 h with LPS, and then for an additional 24 h with different concentrations of A. variegatum saliva. Cells were collected and
stained for surface markers. Expression levels (mean of fluorescence intensity, MFI) of MHC II, CD40, CD80, and CD86 markers on macrophages compared with
unstimulated control cells were measured by flow cytometry. Data are means of triplicate experiments, for a pool of saliva batches for the three animals tested. Blue
lines and shading show the linear regression fit and the 0.95 confidence interval, respectively. The p-value of the model is indicated on the panel.
levels of IL-10 up to 125µg/ml of saliva, increased level of IL-
12 up to 31.25µg/ml then decreased IL-12 in a dose dependent
manner, slightly decreased level of TNF-α in a dose-dependent
manner (Supplementary Figure 2). Unstimulated cells did not
produce NO in the presence of saliva (data not shown).
Molecular Characterization of
A. variegatum Saliva
Proteomics analysis of A. variegatum crude saliva led to the
identification of 336 proteins, with no significant qualitative and
quantitative variation between individuals (PRIDE PXD007821),
allowing us to use pools of saliva for both cell biology assays
and molecular characterization. The protein sequence data,
consisting of the Amblyomma taxonomy (22,429 entries) and
the I. scapularis proteome (UP000001555, 20,473 entries), were
retrieved from UniProtKB (release 2015_03) for identification
purposes. Among the 336 proteins identified, only 58 (17.3%)
A. variegatum specific proteins were identified, knowing that the
UniProtKB A. variegatum specific/particular database contained
753 entries (UniProtKB release 2015_03). Other identified
proteins were divided into 236 Amblyomma (70.2%) and 42 I.
scapularis (12.5%), which is the only ixodid tick species with
a reference proteome in UniProtKB. It should be noted that
58 out of the 336 (17.3%) proteins identified were described as
“Uncharacterized protein.”
Analysis of the nature of the identified proteins by the
ProtFun 2.2 server indicated that 239 out of 336 (71.1%) of
the proteins identified in A. variegatum saliva were enzymes.
The predicted enzymes were further classified in four out
of six different classes (51 Lyases, 25 Ligases, 12 Isomerases,
2 Hydrolases with no Oxidoreductase, and no Transferase),
but 149 remained unclassified. Moreover, Figure 4A shows the
classification of the identified proteins in 12 different functional
categories by the ProtFun 2.2 server, the most widely represented
for A. variegatum saliva being Cell envelope (21.4%), Translation
(9.8%), Energy metabolism (9.5%), and Amino acid biosynthesis
(8.3%). Nevertheless, 38.4% of the identified proteins were not
classified in functional categories (Figure 4A). Figure 4B shows
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FIGURE 3 | Effect of A. variegatum saliva on the production of NO and cytokines by LPS-stimulated bovine macrophages. Bovine blood monocyte-derived
macrophages were pre-stimulated for 1 h with LPS, and then for an additional 24 h with different concentrations of A. variegatum saliva. Cell culture supernatants were
collected and NO production was titrated by the Griess method, IL-10, IL-12, and TNF-α production were titrated by ELISA. Data are means of triplicate experiments,
for a pool of saliva batches for the three animals tested. Blue lines and shading show the linear regression fit and the 0.95 confidence interval, respectively. The p-value
of the model is indicated on the panel.
the prediction scores for 14 gene ontology (GO) categories,
the most frequently represented for A. variegatum saliva being
Growth factor (16.4%) and Immune response (9.8%). Like the
functional categories, 55.2% of the identified proteins were not
classified in the proposed GO categories.
In order to link the molecular data with the biological
data obtained in the cell experiments, we focused on the
characterization of A. variegatum saliva proteins with
immunomodulatory properties already described in the
literature in other tick species. We found 89 out of 336
(26.5%) with a potential role in the modulation of the host
immune response. Among the immunomodulatory proteins,
Table 1 shows a classification into different groups of salivary
proteins with immunomodulatory functions (linked with the
observed effect of A. variegatum saliva on the host immune
cells) as follows: immunogenic proteins including Da-p36
immunosuppressant and Antigen-5 family member (CAP
superfamily of proteins), proteases inhibitors including serpins
and other serine and systeine protease inhibitors, proteases
including serine proteases/serine carboxypeptidases/cathepsin-
like cysteine proteases, ferritin and hemelipoproteins, calcium
binding proteins, fatty acid, and histamine binding protein,
nucleic acid binding proteins, anti-oxidant enzymes, heat shock
proteins.
Twelve proteins were identified as ubiquitin with different
protein IDs from Amblyomma and Ixodes taxa, of which
2 (F0J9P3, F0J9K1) specifically in A. variegatum (Table 2).
Using the Propsearch server, we were able to characterize 6
saliva proteins that exhibited properties of ubiquitin-activating
enzyme E1 ligase, with respective Euclidian distances, giving a
reliability of 99.6% (Table 2). By contrast, we found ubiquitin-
conjugating enzyme E2 ligase with Euclidian distances giving
a percent reliability below the threshold fixed in our analytical
approach (from 68 to 94%), and no ubiquitin-ligating enzyme
E3 ligase (Table 2). However, we found 8 potential de-
ubiquitinating enzymes, mainly ubiquitin carboxyl-terminal
hydrolases, suggesting a complete and potentially functional
ubiquitination system in A. variegatum saliva (Table 2). We
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A
B
FIGURE 4 | Graphic representation of cellular role (A) and selected gene
ontology (GO) categories (B) attributed to proteins identified in the saliva of
A. variegatum by the ProtFun 2.2 Server (http://www.cbs.dtu.dk/services/
ProtFun/). The function prediction server produces ab initio predictions of
protein function from sequences by querying a large number of other feature
prediction servers to obtain information on different post-translational and
localizational aspects of the protein, which are integrated into final predictions
of the cellular role, enzyme class (if any), and selected gene ontology
categories of the sequence submitted.
found the missing link due to the identification of an alpha
spectrin (Table 2), which has the particularity of being described
as a potential chimeric E2/E3 ubiquitin conjugating/ligating
enzyme (Goodman et al., 2015).
Using Propsearch server, we were able to complete
the characterization of A. variegatum saliva proteins with
immunomodulatory properties, by classifying five additional
proteins associated with modulation of the host immune
response as follows (Table 3): a GTP-binding protein
(nucleic-acid binding proteins), a superoxide dismutase
and a D-dopachrome tautomerase (anti-oxidant enzymes), a 60S
ribosomal protein L3 (ribosomal proteins), and another alpha
spectrin (Ubiquitin complex).
DISCUSSION
In the present study, we demonstrated high immunomodulation
of bovine immune cells, lymphocytes and macrophages by
A. variegatum saliva. This adds a new tick species to
the increasing reports on immunomodulation by tick saliva
(Kazimírová and Štibrániová, 2013). Increasing data from the
literature on the interactions between tick saliva and the cells
of the innate and adaptive immune system of vertebrate hosts
tend to demonstrate that excreted-secreted salivary factors
are critical both for completing the tick developmental cycle
via blood feeding and for the transmission/reactivation of
pathogens (Kotál et al., 2015; Šimo et al., 2017). Here,
we showed that A. variegatum saliva induced inhibition of
ConA-induced proliferation of bovine lymphocytes in a dose-
dependent manner. This immunosuppression effect has already
been observed in different tick models, and with various
mitogens, as reviewed by Wikel and Kazimírová (Kazimírová
and Štibrániová, 2013; Wikel, 2013). For example, Ixodes
ricinus salivary glands secreted a protein that suppressed
T lymphocyte proliferation and inhibited macrophage pro-
inflammatory cytokines (Kovár et al., 2001, 2002). Among
Amblyomma ticks, A. cajennense saliva has also been reported to
inhibit lymphocyte proliferation in mouse and horse (Castagnolli
et al., 2008). Another study showed that Dermacentor andersoni
gland extract inhibited the pro-inflammatory cytokine TNF-α
and up-regulated the anti-inflammatory cytokine IL-10, with
down regulation of the expression of MHC II and of co-
stimulation molecules (Wikel, 2013). These effects of saliva
from different tick species, associated with our similar findings
on A. variegatum saliva, strengthen the hypothesis that tick-
host interactions generally result in induced lymphocyte anergy
and reduced macrophage antigen presenting capacity and the
classical activation pathway. In our study, we also showed that
A. variegatum saliva emphasized the macrophage LPS-induced
down regulation of CMH II, decreased the LPS-induced up
regulation of CD40 and CD80. While CD40 binds on CD40-
L on T cells for activation, inhibition of the expression of
this molecule might affect directly the proliferative response of
T-cells, as we observed for ConA-stimulated PBMC subjected
to saliva. Similarly, while CD80 favors a Th1 response, the
inhibition of the expression of LPS-induced CD80 might switch
toward a Th2 response of lymphocytes, switching to an anti-
inflammatory response. This switch has been demonstrated
to be induced by I. ricinus salivary gland extracts (Kovár
et al., 2001, 2002), and plays a role in countering the Th1-
oriented response following tick aggression, as demonstrated
for Rhipichephalus microplus in bovines (Brake and Pérez de
León, 2012). This effect could result in the global inhibition of
antigen presentation capacities and pro-inflammatory activation
pathway of these immune cells, even if they are activated by
the pathogen at the biting site. Furthermore, we evidenced that
A. variegatum saliva also had an effect on NO production by
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TABLE 1 | Potential immunomodulatory proteins identified in A. variegatum saliva.
UniProt
protein IDs
(Leading
protein)
Description Organism Number
of
proteins
Peptides Unique
peptides
Sequence
coverage
[%]
Mol. weight
[kDa]
IMMUNOGENIC PROTEINS
Q75PV7 Protein related to Da-p36 A. variegatum 1 6 6 29.7 27.443
F0J8E1 Antigen-5 family member (Fragment) A.variegatum 1 2 2 32.7 12.308
PROTEASE INHIBITORS INCLUDING
Serpins
F0J9G9 Serpin (Fragment) A. variegatum 6 11 9 59.3 23.07
F0J8P8 Serpin (Fragment) A. variegatum 1 5 5 57.1 17.759
F0J8R0 Serpin (Fragment) A. variegatum 1 2 1 29.1 17.208
A0A023GPF9 Putative tick serpins 14 A. triste 6 6 6 14.7 44.703
A0A023GN51 Putative tick serpins 13 A. triste 6 5 1 12.1 42.841
A0A023GP80 Putative tick serpins 27 A. triste 2 3 2 7.6 43.538
A0A023FPT3 Putative tick serpins 7 (Fragment) A. cajennense 1 2 2 7.5 35.74
A0A023GGH1 Putative tick serpins 33 (Fragment) A. triste 1 2 2 8.5 26.402
A0A023FUL1 Putative tick serpins 12 (Fragment) A. cajennense 3 2 2 7.8 46.875
A0A023GPF5 Putative tick serpins 13 A. triste 2 2 1 9.3 42.797
G3MLB1 Putative uncharacterized protein (tick serpins
27)
A. maculatum 15 3 1 9.6 43.103
Other serine protease inhibitors
F0J9Y3 Kazal-type serine protease inhibitor domain
protein
A. variegatum 4 3 3 20 26.71
A0A023GE28 Putative serine protease inhibitor I. scapularis
serine protease inhibitor (Fragment)
A. triste 2 6 6 18.5 46.98
A0A023GE28 Putative serine protease inhibitor I. scapularis
serine protease inhibitor (Fragment)
A. triste 2 6 6 18.5 46.98
A0A023FQ10 Putative serine protease inhibitor I. scapularis
serine protease inhibitor
A. cajennense 1 2 2 5.1 44.715
A0A023GPF6 Putative serine proteinase inhibitor A. triste 2 2 1 8.4 43.504
Cysteine protease inhibitors
A0A023FR27 Putative thyropin A. cajennense 6 2 2 12.4 22.395
F0JA40 Putative thyropin A. variegatum 7 3 3 12.7 22.532
PROTEASES INCLUDING
Serine proteases
F0J9J5 Trypsin-like serine protease (Fragment) A. variegatum 1 6 6 41.1 21.867
F0J9E7 Trypsin-like serine protease (Fragment) A. variegatum 3 6 4 48.9 19.618
Serine carboxypeptidases
A0A023GNB7 Putative serine carboxypeptidase lysosomal
cathepsin a
A. triste 1 1 1 5.2 53.097
Cathepsin-like cysteine proteases
F0JA27 Cathepsin L-like cysteine proteinase B A. variegatum 8 10 9 36.8 37.624
F0J903 Cysteine proteinase cathepsin L (Fragment) A. variegatum 2 5 5 38.6 23.017
G3MHB0 Putative uncharacterized protein (Fragment)
(peptidase C1 family; cathepsin l-like cysteine
proteinase b)
A. maculatum 3 2 1 11.5 38.867
FERRITIN AND HEMELIPOPROTEINS
G3MPJ3 Ferritin A. maculatum 2 3 3 19.5 22.296
F0J8W4 Heme lipoprotein (Fragment) A. variegatum 2 33 22 63.5 50.007
F0J9N1 Heme lipoprotein (Fragment) A. variegatum 1 20 18 67.4 27.005
F0J9N8 Hemelipoglycoprotein (Fragment) A. variegatum 1 14 14 48.2 24.787
F0J9G0 Heme lipoprotein (Fragment) A. variegatum 1 11 8 95.4 14.828
A0MVX0 Heme lipoprotein A. americanum 1 31 5 16.3 177.04
(Continued)
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TABLE 1 | Continued
UniProt
protein IDs
(Leading
protein)
Description Organism Number
of
proteins
Peptides Unique
peptides
Sequence
coverage
[%]
Mol. weight
[kDa]
B7Q406 Hemelipoglycoprotein. putative I. scapularis 2 3 1 1.7 177.65
B7QIL0 Hemelipoglycoprotein. putative (Fragment) I. scapularis 1 2 1 1.3 172.44
CALCIUM BINDING PROTEINS
F0JA25 Calreticulin A. variegatum 1 4 1 16.3 47.318
Q64KA0 Calreticulin A. brasiliense 17 4 1 16.3 47.241
G3MK71 Calponin A. maculatum 6 3 3 24.7 17.614
FATTY ACID AND HISTAMINE BINDING PROTEIN
A0A023G6C8 Putative lipocal-1 1 A. triste 1 1 1 8.5 24.71
A0A023GBM1 Putative phospholipase a2 I. scapularis
phospholipase a2
A. triste 2 4 4 11.4 44.79
NUCLEIC ACID BINDING PROTEINS
G3MSL8 Putative uncharacterized protein (Putative
gtp-binding protein)
A. maculatum 10 2 2 12.4 24.689
G3MRA1 Putative uncharacterized protein (gtp-binding
protein)
A. maculatum 4 1 1 6 22.968
A0A023FGS1 Putative zinc-binding protein of the histidine
triad hit family
A. cajennense 3 1 1 11.1 13.53
ANTI-OXYDANT ENZYMES
A0A023FIC2 Putative glutathione s-transferase mu class
Rhipicephalus annulatus glutathione
s-transferase
A. cajennense 7 6 6 29.1 25.713
A0A023GJM3 Putative glutathione s-transferase A. triste 2 2 2 14.7 24.394
A0A023FXR2 Putative glutathione s-transferase I. scapularis
glutathione s-transferase
A. parvum 5 2 2 10.4 26.241
A0A023FFS7 Putative glutathione s-transferase I. scapularis
glutathione s-transferase
A. cajennense 1 1 1 5.5 24.303
A0A023FQ81 Putative glutathione s-transferase I. scapularis
glutathione s-transferase (Fragment)
A. cajennense 4 1 1 8.9 23.244
A0A023G5I8 Putative glutathione s-transferase I. scapularis
glutathione s-transferase (Fragment)
A. triste 4 1 1 8.6 27.412
B7PDV0 Glutathione S-transferase. putative I. scapularis 4 1 1 12.2 8.6628
G3MMK0 Putative uncharacterized protein (glutathione
s-transferase I. scapularis glutathione
s-transferase)
A. maculatum 2 1 1 5.9 26.159
A0SHR2 Protein disulfide-isomerase A. variegatum 8 3 3 7.2 54.923
A0A023FZW2 Protein disulfide-isomerase A. parvum 5 4 1 9.2 57.252
A0A023FNM6 Putative alkyl hydroperoxide reductase thiol
specific antioxidant (Fragment)
A. cajennense 2 2 2 10.7 23.542
A0A023FHT1 Putative thioredoxin peroxidase A. cajennense 14 4 4 24 20.494
A0A023FDL5 Putative selenoprotein w 2a A. cajennense 1 1 1 22.1 8.6959
F0J9H3 Peroxidasin (Fragment) A. variegatum 1 1 1 8.1 27.07
A0A023FTX2 Superoxide dismutase [Cu-Zn] A. parvum 1 1 1 9.7 15.744
HEAT SHOCK PROTEINS
A0A023GNY6 Putative heat shock protein (Fragment) A. triste 11 16 13 35.6 73.124
A0A023GP15 Putative heat shock protein 90 A. triste 9 7 2 13.5 84.001
A0A023GLJ3 Putative heat shock protein 70 A. triste 7 5 2 10.5 73.014
A0A023FRH0 Putative heat shock protein A. cajennense 1 1 1 5.7 21.73
G3MF27 Putative uncharacterized protein (heat shock
70 kDa protein 5)
A. maculatum 7 4 3 8 69.078
G3MF42 Putative uncharacterized protein (heat shock
protein)
A. maculatum 2 1 1 7.8 21.722
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macrophages through complex modulation of this microbicidal
and immunosuppressive molecule (Wink et al., 2011): it
increased its production at relatively low concentrations but
decreased its production at high concentrations. Macrophages
use NO together with several other free radicals as a mechanism
for killing pathogens and inducing an inflammatory response,
but high levels of NO has been shown to have suppressive effects
on lymphocyte proliferation (MacMicking et al., 1997). We
observed that NO production was increased by small quantities
of saliva (31.25–62.5µg/ml), then strongly decreased by high
concentrations of saliva (up to 250µg/ml). This inhibition
correlated with the decrease in TNF-α and the increase in IL-10
we observed when the global in vitro immune response became
clearly anti-inflammatory. It is possible that high production
of NO plays a role in the establishment of lymphocyte anergy,
before the deactivation of macrophages by A. variegatum saliva
avoids tissue damage in the host that would be deleterious to tick
feeding. In a previous study on A. variegatum saliva performed
in the in vivo mouse model, we showed that, in skin lesions
mimicking tick biting, A. variegatum saliva impairs leukocyte
infiltration (Vachiery et al., 2015). Experiments in an in vitro
human model further demonstrated that tick saliva impaired
the migration of antigen presenting cells to the draining lymph
nodes and affected the recruitment of blood monocytes to the
skin lesion and prevented their maturation in situ (Vachiery
et al., 2015). These results strengthen our findings with bovine
cells, and show how the saliva of A. variegatum, by modulating
chemotaxis, the proliferative capacity of lymphocytes, the
regulatory capacities of macrophages, diverts the host’s immune
system to its own advantage, and the consequences this may have
for the transmission or reactivation of pathogens.
Some of the strong and specific effects of tick saliva
in modulating cytokine production by macrophage and
lymphocytes, and hence the impacts on immune response, can
be analyzed at molecular scale to characterize saliva molecules
thanks to the advent of proteomics. Among the proteins we
evidenced in A. variegatum female saliva and shown to have
direct immunomodulatory functions, the CAP superfamily
of proteins (comprising the CRISP, Antigen-5, and pathogen-
related-1 families) has been found in most tick sialomes studied
to date, with molecular characteristics similar to wasp-venom
proteins and annotated as Antigen-5 (Gibbs et al., 2008).
Additionally, recombinant Da-p36 has been demonstrated to
suppress T-lymphocyte-mitogen-driven in vitro proliferation of
splenocytes (Alarcon-Chaidez et al., 2003), and could therefore
be part of the molecular mechanism behind our observation
of inhibition lymphocyte proliferation in the presence of
A. variegatum saliva.
The most representative category of proteins with potential
immunomodulatory properties we identified were protease
inhibitors, mainly serpins. Serpins are abundant in ticks, and
one of their functions is to modulate the host immune system
(Chmelar et al., 2017). The first tick serpin described for
its effect on host defense mechanisms was named I. ricinus
immunosuppressor (Iris) and was able to inhibit T-cell and
splenocyte proliferation and to modify cytokine levels derived
from PBMC (Leboulle et al., 2002), as well as to bind
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to monocytes/macrophages and to suppress TNF-α secretion
(Prevot et al., 2009). These results are very similar to our
observations, and we hypothesize the existence of an Iris-like
protein among the serpins identified in A. variegatum saliva.
Other protease inhibitors we identified are cysteine protease
inhibitors named thyropins. Recently, an exogenous thyropin
was shown to affect IL-12 secretion of dendritic cells (DCs)
(Zavašnik-Bergant and Bergant Marušicˇ, 2016), which leads us
think that the thyropins inA. variegatum saliva could be involved
in the decreased production of IL-12 by bovine macrophages, like
DCs. In contrast to protease inhibitors, we identified proteases in
the saliva ofA. variegatum, whose carboxypeptidases could play a
role in the destruction of inflammatory peptide agonists (Ribeiro
et al., 2011) and cathepsin-like cysteine proteases could destroy
cellular mediators of inflammation (Radulovic´ et al., 2014).
During tick feeding, the processing of the blood meal is
accompanied by a high risk of oxidative stress linked to large
amounts of heme, a bi-product of hemoglobin digestion, and
free iron in the host’s blood (Graca-Souza et al., 2006). We
identified ferritin and hemelipoproteins in A. variegatum saliva,
which could be used to dump heme and free iron in the host
to avoid oxidative stress, and at the same time benefit tick-
borne pathogens that may need iron to proliferate (Rouault,
2004).We also found numerous anti-oxidant enzymes (including
glutathione-S transferase (GST), protein disulfide isomerase,
thioredoxin peroxidase, peroxidasin, superoxide dismutase, and
selenoproteins) in the saliva of A. variegatum, which could
play a role in reducing the toxicity of reactive oxygen and
nitrogen species (such as NO) produced as part of the wound
healing mechanism and anti-microbial defenses (Vider et al.,
2001; Rojkind et al., 2002). Preventing damage caused by
oxidative stress could benefit both the host and the tick,
but given the susceptibility of pathogens to the products of
oxidative stress, anti-oxidants in tick saliva could facilitate
the transmission of tick-borne pathogens. Interestingly, we
found D-dopachrome tautomerase, the functional homolog of
macrophage migration inhibitory factor (MIF) (Merk et al.,
2011), which is a pro-inflammatory cytokine produced by
ticks to regulate host responses to tick feeding (Wasala et al.,
2012). D-dopachrome tautomerase/MIF could be involved in
the immunological silence induced by A. variegatum, with
no chemotactic recruitment of host macrophages. Conversly,
we evidenced several proteins dedicated to anti-inflammatory
response. For instance, extracellular nucleic acids are potent
proinflammatory molecules, and nucleic acid binding proteins
could be part of the system used by the tick to modulate host
inflammation (Radulovic´ et al., 2014). In the sameway, ribosomal
and heat shock proteins have been described as potent anti-
inflammatory molecules (Pockley, 2003; Poddar et al., 2013).
Fatty acid and histamine binding proteins also play roles in
preventing inflammation during tick feeding. Histamine is a
potent pro-inflammatory molecule that is released by cellular
mediators of inflammation such as mast cells and neutrophils
(White and Kaliner, 1987). Like A. americanum, A. variegatum
saliva contains histamine-binding protein/lipocalin to sequester
histamine and stop the corresponding inflammatory response
(Radulovic´ et al., 2014). Although other authors have
demonstrated secretion of prostaglandin E2 (PGE2) and
prostacyclin (PGI) in tick saliva (Ribeiro et al., 1988; Bowman
et al., 1995), we did not identify these proteins among our
FIGURE 5 | Synthetic view of A. variegatum salivary-induced modulation of bovine immune cells Molecular determinants (with immunomodulatory properties identified
by proteomics) driving cellular events (inhibition of lymphocyte proliferation, modulation of macrophage activation) evidenced in the study are summarized in the
scheme.
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proteomics data. However, we did identify a phospholipase A2,
which could stimulate prostacyclin production (Bowman et al.,
1997) and induce PGE2 production by host cells (Hara et al.,
1991; Miyake et al., 1994). Tick saliva PGE2 has been shown to
modulate the function of macrophages, particularly cytokine
profiles (Poole et al., 2013), as we also evidenced in our study.
Indirect PGI and PGE2 regulation could have been developed
by A. variegatum to manipulate host macrophages, which, as a
central immune cell, could pervert the whole immune system of
the host.
Multifunctional calcium binding proteins, such as calponin
and calreticulin (CRT), are present in the saliva of A. variegatum
but apart from depleting Ca2+ to prevent activation of blood
clotting (Astrup, 2009), their function is not yet known.
Nevertheless, an interesting hypothesis has emerged from A.
americanum CRT, which could skew a Th-2 host response
to tick feeding (Kim et al., 2015), and which is consistent
with our observation of a M2-induced profile of macrophage
cytokines/metabolism by A. variegatum saliva.
Finally, we also discovered an original ubiquitination complex
in the saliva of A. variegatum, both on its molecular architecture
and on its extracellular localization. In eukaryote cells, ubiquitin
is transferred by three enzymes: the ubiquitin-activating enzyme
E1 ligase catches ubiquitin and transfers it to the ubiquitin-
conjugating enzyme E2 ligase, which associates with ubiquitin-
ligating enzyme E3 ligase to transfer ubiquitin to the target
substrate (Tanaka et al., 1998). Intriguingly, the ubiquitination
we evidenced in A. variegatum is simplified with spectrin
playing the role of a chemeric E2/E3 ubiquitin-conjugating-
ligating enzyme (Goodman et al., 2015). Whereas, ubiquitination
has long been well described in connection with proteasome
degradation of proteins, in the last decade, an increasing
literature has proposed an important role for ubiquitination in
immunity (Ben-Neriah, 2002; Zinngrebe et al., 2014), particularly
in regulating both innate and adaptive immune responses
(Malynn and Ma, 2010; Park et al., 2014; Hu and Sun, 2016).
Interestingly, extracellular ubiquitin has been implicated in
lymphocyte differentiation, suppression of the immune response,
and prevention of inflammation (Sujashvili, 2016), particularly
by binding to the CXCR4 receptor (Majetschak, 2011; Scofield
et al., 2015). Moreover, extracellular ubiquitin can bind directly
to regulatory T cells; enhancing their inhibitory effect on effector
T cells proliferation (Cao et al., 2014). Exogenous ubiquitin can
also reduce TNF-α production (Majetschak et al., 2004). The last
two elements are in complete agreement with our observations
on inhibition of lymphocyte proliferation and reduction of TNF-
α production by macrophages in the presence of tick saliva,
and make us suggest that A. variegatum uses its extracellular
ubiquitination complex as an effective molecular weapon for
render the immune responses of the host ineffective during the
blood meal.
To conclude, our data shed new light on the
molecular determinants of A. variegatum saliva-induced
immunomodulation of bovine immunity cells and allows us to
propose a new synthesis scheme of the cellular and molecular
events that take place at the tick-host interface (Figure 5).
Further studies on the effect of A. variegatum saliva on bovine
PBMC and macrophages are needed to better understand
the mechanisms underlying our observations, particularly
the comparative effect of saliva on different lymphocyte
sub-populations such as cytotoxic T cells or NK cells, but
also qualitative or quantitative cytokine modulation such as
INF-γ, IL-2, IL-4, or IL-17 with impacts on Th1/Th2 or Th17
balance, as shown in I. ricinus (Kopecký et al., 1999; Kovár
et al., 2001; Leboulle et al., 2002) and in mosquitoes (Wanasen
et al., 2004). Effects on macrophages presenting capacities
also need to be elucidated in connection with pathogen
uptake and presentation in the presence of tick saliva. These
cellular investigations will need to be combined with further
molecular characterization of saliva proteins to identify the
key molecules in immunomodulation mechanisms. Overall,
our data provide new insights into tick-ruminant interactions
for A. variegatum, including their involvement in vectorial
competence for pathogen transmission (E. ruminantium
infection) or on pathogen reactivation (dermatophilosis),
and pave the way for integrative strategies to interfere with
both the immunosuppressive and infectious processes in the
corresponding tick-borne diseases.
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Supplementary Figure 1 | Effect of A. variegatum saliva on the expression of
surface molecules of bovine unstimulated macrophages. Bovine blood
monocyte-derived macrophages were cultivated for 24 h with different
concentrations of A. variegatum saliva. Cells were collected and stained for MHC
II, CD40, CD80, and CD86 surface markers. Expression levels (mean of
fluorescence intensity, MFI) of markers on macrophages compared to those on
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control unstimulated cells were measured by flow cytometry. Blue lines and
shading show the linear regression fit and the 0.95 confidence interval,
respectively. The p-value of the model is indicated on the panel.
Supplementary Figure 2 | Effect of A. variegatum saliva on the production of
cytokines by bovine unstimulated macrophages. Bovine blood monocyte-derived
macrophages were stimulated for 24 h with different concentrations of
A. variegatum saliva. Cell culture supernatants were collected and IL-10, IL-12,
and TNF-α production was titrated by ELISA. (Data are results obtained for one
experiment performed on three different animals; note different scales on graphs).
Blue lines and shading show the linear regression fit and the 0.95 confidence
interval, respectively. The p-value of the model is indicated on the panel.
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